These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 37530792)
1. Aggressive B-cell non-Hodgkin lymphomas: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology. Rodriguez-Pinilla SM; Dojcinov S; Dotlic S; Gibson SE; Hartmann S; Klimkowska M; Sabattini E; Tousseyn TA; de Jong D; Hsi ED Virchows Arch; 2024 Jan; 484(1):15-29. PubMed ID: 37530792 [TBL] [Abstract][Full Text] [Related]
2. Emerging entities: high-grade/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with IRF4 rearrangement, and new molecular subgroups in large B-cell lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop. Quintanilla-Martinez L; Laurent C; Soma L; Ng SB; Climent F; Ondrejka SL; Zamo A; Wotherspoon A; de Leval L; Dirnhofer S; Leoncini L Virchows Arch; 2023 Sep; 483(3):281-298. PubMed ID: 37555980 [TBL] [Abstract][Full Text] [Related]
3. Genetic and phenotypic characterisation of HIV-associated aggressive B-cell non-Hodgkin lymphomas, which do not occur specifically in this population: diagnostic and prognostic implications. Baptista MJ; Tapia G; Muñoz-Marmol AM; Muncunill J; Garcia O; Montoto S; Gribben JG; Calaminici M; Martinez A; Veloza L; Martínez-Trillos A; Aldamiz T; Menarguez J; Terol MJ; Ferrandez A; Alcoceba M; Briones J; González-Barca E; Climent F; Muntañola A; Moraleda JM; Provencio M; Abrisqueta P; Abella E; Colomo L; García-Ballesteros C; Garcia-Caro M; Sancho JM; Ribera JM; Mate JL; Navarro JT Histopathology; 2022 Dec; 81(6):826-840. PubMed ID: 36109172 [TBL] [Abstract][Full Text] [Related]
4. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma. Snuderl M; Kolman OK; Chen YB; Hsu JJ; Ackerman AM; Dal Cin P; Ferry JA; Harris NL; Hasserjian RP; Zukerberg LR; Abramson JS; Hochberg EP; Lee H; Lee AI; Toomey CE; Sohani AR Am J Surg Pathol; 2010 Mar; 34(3):327-40. PubMed ID: 20118770 [TBL] [Abstract][Full Text] [Related]
5. [Fluorescence in situ hybridization in the diagnosis of aggressive B-cell lymphomas]. Gerhard-Hartmann E; Rosenwald A Pathologe; 2020 Nov; 41(6):574-581. PubMed ID: 32909092 [TBL] [Abstract][Full Text] [Related]
6. A Diagnostic Approach to the Identification of Burkitt-like Lymphoma With 11q Aberration in Aggressive B-Cell Lymphomas. Horn H; Kalmbach S; Wagener R; Staiger AM; Hüttl K; Mottok A; Bens S; Traverse-Glehen A; Fontaine J; Siebert R; Rosenwald A; Ott G Am J Surg Pathol; 2021 Mar; 45(3):356-364. PubMed ID: 33136583 [TBL] [Abstract][Full Text] [Related]
7. Motive and opportunity: MYC rearrangements in high-grade B-cell lymphoma with MYC and BCL2 rearrangements (an LLMPP study). Hilton LK; Collinge B; Ben-Neriah S; Alduaij W; Shaalan H; Weng AP; Cruz M; Slack GW; Farinha P; Miyata-Takata T; Boyle M; Meissner B; Cook JR; Ondrejka SL; Ott G; Rosenwald A; Campo E; Amador C; Greiner TC; Raess PW; Song JY; Inghirami G; Jaffe ES; Weisenburger DD; Chan WC; Beiske K; Fu K; Delabie J; Pittaluga S; Iqbal J; Wright G; Sehn LH; Savage KJ; Mungall AJ; Feldman AL; Staudt LM; Steidl C; Rimsza LM; Morin RD; Scott DW Blood; 2024 Aug; 144(5):525-540. PubMed ID: 38701426 [TBL] [Abstract][Full Text] [Related]
8. MYC single-hit large B-cell lymphoma: clinicopathologic difference from MYC-negative large B-cell lymphoma and MYC double-hit/triple-hit lymphoma. Cho YA; Hyeon J; Lee H; Cho J; Kim SJ; Kim WS; Ko YH Hum Pathol; 2021 Jul; 113():9-19. PubMed ID: 33771538 [TBL] [Abstract][Full Text] [Related]
9. New developments in non-Hodgkin lymphoid malignancies. Ganapathi KA; Brown LE; Prakash S; Bhargava P Pathology; 2021 Apr; 53(3):349-366. PubMed ID: 33685720 [TBL] [Abstract][Full Text] [Related]
10. Application of 2016 WHO classification in the diagnosis of paediatric high-grade Zhang L; Brown LE; Bowen LM; McCarthy LC; Cooley LD; Repnikova E; Gener MA; Garola R; August KJ; Hays JA; Zwick DL; Li W J Clin Pathol; 2020 Sep; 73(9):563-570. PubMed ID: 31964683 [TBL] [Abstract][Full Text] [Related]
11. Clinicopathological and genomic analysis of double-hit follicular lymphoma: comparison with high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements. Miyaoka M; Kikuti YY; Carreras J; Ikoma H; Hiraiwa S; Ichiki A; Kojima M; Ando K; Yokose T; Sakai R; Hoshikawa M; Tomita N; Miura I; Takata K; Yoshino T; Takizawa J; Bea S; Campo E; Nakamura N Mod Pathol; 2018 Feb; 31(2):313-326. PubMed ID: 28984304 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic approaches and future directions in Burkitt lymphoma and high-grade B-cell lymphoma. King RL; Hsi ED; Chan WC; Piris MA; Cook JR; Scott DW; Swerdlow SH Virchows Arch; 2023 Jan; 482(1):193-205. PubMed ID: 36057749 [TBL] [Abstract][Full Text] [Related]
13. Screening Strategy for Detecting Double-Hit Lymphoma in a Resource-Limited Setting. Thirunavukkarasu B; Bal A; Prakash G; Malhotra P; Singh H; Das A Appl Immunohistochem Mol Morphol; 2022 Jan; 30(1):49-55. PubMed ID: 34456240 [TBL] [Abstract][Full Text] [Related]
14. Burkitt Lymphoma and Other High-Grade B-Cell Lymphomas with or without MYC, BCL2, and/or BCL6 Rearrangements. Alsharif R; Dunleavy K Hematol Oncol Clin North Am; 2019 Aug; 33(4):587-596. PubMed ID: 31229156 [TBL] [Abstract][Full Text] [Related]
15. Comprehensive Assessment and Classification of High-Grade B-cell Lymphomas. Behdad A; Bailey NG Surg Pathol Clin; 2016 Mar; 9(1):41-54. PubMed ID: 26940267 [TBL] [Abstract][Full Text] [Related]
16. [Classification of aggressive B-cell lymphomas : News and open questions]. Rosenwald A; Menter T; Dirnhofer S Pathologie (Heidelb); 2023 May; 44(3):166-172. PubMed ID: 36918411 [TBL] [Abstract][Full Text] [Related]
18. B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome. Li S; Lin P; Fayad LE; Lennon PA; Miranda RN; Yin CC; Lin E; Medeiros LJ Mod Pathol; 2012 Jan; 25(1):145-56. PubMed ID: 22002575 [TBL] [Abstract][Full Text] [Related]
19. EBV Liu H; Xu-Monette ZY; Tang G; Wang W; Kim Y; Yuan J; Li Y; Chen W; Li Y; Fedoriw GY; Zhu F; Fang X; Luedke C; Medeiros LJ; Young KH; Hu S Histopathology; 2022 Feb; 80(3):575-588. PubMed ID: 34637146 [TBL] [Abstract][Full Text] [Related]
20. ID3 mutations are recurrent events in double-hit B-cell lymphomas. Gebauer N; Bernard V; Feller AC; Merz H Anticancer Res; 2013 Nov; 33(11):4771-8. PubMed ID: 24222112 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]